CHUNLI MEDICAL (01858) · Company profile · Eqvero

CHUNLI MEDICAL

01858HKEX

Unit: CNY	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	1.04 bn CNY	805.22 m CNY	1.21 bn CNY	1.2 bn CNY	1.11 bn CNY
Cost of revenue	350.56 m CNY	251.69 m CNY	318.69 m CNY	271.49 m CNY	245.81 m CNY
Research and development expense	118.5 m CNY	133.1 m CNY	157.45 m CNY	162.34 m CNY	104.84 m CNY
Selling, general and administrative expense	250.44 m CNY	285.54 m CNY	427.61 m CNY	430.31 m CNY	372.73 m CNY
Operating profit after depreciation	270.27 m CNY	91.96 m CNY	254.86 m CNY	281.35 m CNY	344.44 m CNY
Operating profit before depreciation	312.08 m CNY	129.64 m CNY	289.51 m CNY	311.38 m CNY	362.75 m CNY
EBIT	270.27 m CNY	91.96 m CNY	254.86 m CNY	281.35 m CNY	344.44 m CNY
EBITDA	312.08 m CNY	129.64 m CNY	289.51 m CNY	311.38 m CNY	362.75 m CNY
Interest expense	39 k CNY	45 k CNY	86 k CNY	—	—
Profit before tax	301.71 m CNY	131.6 m CNY	305.91 m CNY	336.88 m CNY	367.38 m CNY
Income tax expense	29.09 m CNY	6.94 m CNY	28.09 m CNY	29.16 m CNY	45.02 m CNY
Income before extraordinary items	272.54 m CNY	124.99 m CNY	277.82 m CNY	307.72 m CNY	322.36 m CNY
Common dividends	137.59 m CNY	50.52 m CNY	138.85 m CNY	12.01 m CNY	49.96 m CNY
Total dividends	137.59 m CNY	50.52 m CNY	138.85 m CNY	12.01 m CNY	49.96 m CNY

Quotes are end-of-day data. Content is for research purposes and is not investment advice.